Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

MSBase Study Group, Anna He, Tim Spelman, Vilija Jokubaitis, Eva Havrdova, Dana Horakova, Maria Trojano, Alessandra Lugaresi, Guillermo Izquierdo, Pierre Grammond, Pierre Duquette, Marc Girard, Eugenio Pucci, Gerardo Iuliano, Raed Alroughani, Celia Oreja-Guevara, Ricardo Fernandez-Bolaños, Francois Grand'Maison, Patrizia Sola, Daniele SpitaleriFranco Granella, Murat Terzi, Jeannette Lechner-Scott, Vincent Van Pesch, Raymond Hupperts, José Luis Sánchez-Menoyo, Suzanne Hodgkinson, Csilla Rozsa, Freek Verheul, Helmut Butzkueven, Tomas Kalincik, Mark Slee, Michael Barnett

Research output: Contribution to journalArticlepeer-review

101 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science